IDH1-R123与Notch1突变在儿童急性T淋巴细胞白血病中的作用机制(5)
[23] 曹江，韓笑，徐开林. CD19嵌合抗原受体T细胞治疗后急性B淋巴细胞白血病的复发机制及对策防治[J]. 国际输血及血液学杂志，2019，42(2)：103-108.
[24] Hamid Bolouri，Jason E Farrar，Timothy Triche Jr，et al. The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions[J]. Nature Medicine，2018，24(1)：103.
[25] 房建铭，田新，杨春会，等. 93例儿童急性B淋巴细胞白血病IKZF1基因缺失的临床研究[J]. 国际输血及血液学杂志，2018，41(6)：480-484.
[26] Anne-Laure Gagez，Isabelle Duroux-Richard，Stéphane Leprêtre，et al. miR-125b and miR-532-3p predict efficiency of the rituximab-mediated lymphodepletion in chronic lymphocytic leukemia patients. A FILO study[J]. Haematologica，2017，102(4)：haematol.2016.153189.
[27] 王天怡，汤静燕，李本尚. 酪氨酸激酶抑制剂在儿童Ph阳性急性淋巴细胞白血病的治疗进展[J]. 国际输血及血液学杂志，2017，40(4)：344-348.
[28] Baliakas P，Mattsson M，Hadzidimitriou A，et al. No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy[J]. Haematologica，2018，103(4)：e158.
[29] Leiming Xia，Qian Chen，Qiao Li，et al. Abstract CT041：The clinical study on CD19-directed chimeric antigen receptor-modified T cells in patient with Richter syndrome[J]. Cancer Research，2017，77(13 Supplement)：CT041.
(收稿日期：2020-01-15), http://www.100md.com(王晓丽 刘永华 江锦红)
[24] Hamid Bolouri，Jason E Farrar，Timothy Triche Jr，et al. The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions[J]. Nature Medicine，2018，24(1)：103.
[25] 房建铭，田新，杨春会，等. 93例儿童急性B淋巴细胞白血病IKZF1基因缺失的临床研究[J]. 国际输血及血液学杂志，2018，41(6)：480-484.
[26] Anne-Laure Gagez，Isabelle Duroux-Richard，Stéphane Leprêtre，et al. miR-125b and miR-532-3p predict efficiency of the rituximab-mediated lymphodepletion in chronic lymphocytic leukemia patients. A FILO study[J]. Haematologica，2017，102(4)：haematol.2016.153189.
[27] 王天怡，汤静燕，李本尚. 酪氨酸激酶抑制剂在儿童Ph阳性急性淋巴细胞白血病的治疗进展[J]. 国际输血及血液学杂志，2017，40(4)：344-348.
[28] Baliakas P，Mattsson M，Hadzidimitriou A，et al. No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy[J]. Haematologica，2018，103(4)：e158.
[29] Leiming Xia，Qian Chen，Qiao Li，et al. Abstract CT041：The clinical study on CD19-directed chimeric antigen receptor-modified T cells in patient with Richter syndrome[J]. Cancer Research，2017，77(13 Supplement)：CT041.
(收稿日期：2020-01-15), http://www.100md.com(王晓丽 刘永华 江锦红)